期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

髓源性抑制细胞与肿瘤 被引量：1

下载PDF
导出
摘要 髓源性抑制细胞(myeloid-derived suppressor cells,MD-SCs)是一类具有显著免疫抑制活性的异质细胞群,其通过抑制效应T细胞功能从而介导肿瘤免疫逃逸,促进肿瘤生长。该文就MDSCs在肿瘤免疫逃逸中的作用机制、肿瘤微环境中的各种细胞因子对MDSCs的影响及各种免疫活性细胞与MDSCs间的相互作用作一综述。
作者 常雪姣 朱明华
机构地区 第二军医大学附属长海医院病理科
出处 《临床与实验病理学杂志》 CAS CSCD 北大核心 2013年第2期200-203,共4页 Chinese Journal of Clinical and Experimental Pathology
基金 国家自然科学基金(81172310)
关键词 肿瘤 微环境 髓源性抑制细胞 免疫抑制 免疫耐 受 文献综述
分类号 R730 [医药卫生—肿瘤]
  • 相关文献

参考文献24

  • 1Gabriluvich D l, Nagaraj S. Myeloid-derived-suppressor cells as regulators of the immune system[ J ]. J Nat Rev lmmunol, 2009,9 (3) :162 -74.
  • 2李媛,胡正军.髓源性抑制细胞-免疫系统的调节成分[J].现代检验医学杂志,2011,26(2):58-61. 被引量：4
  • 3He D G, Li H, Yusuf N, et al. IL-17 promotes tumor develop- ment through the induetion of tumor promoting mieroenvironments at tumor sites and myeloid derived suppressor cells[ J ]. J hnmu- nol, 2010,184 ( 5 ) :2281 - 8.
  • 4Greten T F, Manns M P, Korangy F. Myeloid derived suppressor cells in human diseases [ J]. lnt Immunopharrnacol, 2011, 11 (7) :802 -7.
  • 5La Face D, Talmadge J. Meeting report:regulatory myeloid cells [J]. lnt lmmumlpharrnacol, 2011 , 11 ( 7 ) :780 - 2.
  • 6Peranzoni E, Marigo I,Doleetti L, et ctl. Role of arginine metabo- lism in immunity and immunopathology [ J]. Immunobiology, 2007,212(9) :795 -812.
  • 7Cnrzo C A, Cotter M J, Cheng P Y, et al. Meehanism regulating reactive oxygen species in tumor induced myeloid-derived suppres- sor cells: MDSC and ROS in eaneer[ J ]. J hnmunol, 2009,182 (9) :5693 -701.
  • 8Nagaraj S, Gabrihwich D I. Tumor escape mechanism governed by myeloid-derived suppressor cells[ J ]. Cancer Res, 2008,68 ( 8 ) : 2561 - 3.
  • 9Nagaraj S, Schrum A G, Dmitty 1, et al. Meehanism of T-eell tol- erance imlueed by myeloid-derived suppressor eells [ J ]. J hnmu- nol, 2010,184(6) :3106 - 16.
  • 10Srivastava M K, Sinha P, Clements V K, et al. Myeloid-derived suppressor eells inhibit T cell activation by depleting eystine and cysteine[J]. Cancer Res, 2010,70(1):68-77.

二级参考文献29

  • 1Winfield RD,Delano MJ,Pande K,et al.Myeloid-Derived Suppressor Cells in Cancer Cachexia Syndrome:A New Explanation for an Old Problem[J].Journal of Parenteral and Enteral Nutrition,2008,32(6):651-655.
  • 2Young MR,Newby M,Wepsic HT.Hematopoiesis and suppressor bone marrow cells in mice bearing large metastatic Lewis lung carcinoma tumors[J].Cancer Res,1987,47(1):100-105.
  • 3Youn JI,Nagaraj S,Collazo M,et al.Subsets of my-eloid-derived suppressor cells in tumor-bearing mice[J].J Immunol,2008,181(8):5791-5802.
  • 4Almand B,Clark JI,Nikitina E,et al.Increased production of immature myeloid cells in cancer patients.A mechanism of immunosuppression in cancer[J].J Immunol,2001,166(1):678-689.
  • 5Schmielau J,Finn OJ.Activated granulocytes and gr-anulocyte-derived hydrogen peroxide are the underlying mechanism of suppression of T-cell function in advanced cancer patients[J].Cancer Res,2001,61(12):4756-4760.
  • 6Diaz-Montero CM,Salem ML,Nishimura MI,et al.Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage,metastatic tumor burden,and doxorubicin-cyclophosphamide chemotherapy[J].Cancer Immunol Immunother,2009,58(1):49-59.
  • 7Ko JS,Bukowski RM,Fincke JH.Myeloid-derived suppressor cells:a novel therapeutic target[J].Curr Oncol Rep,2009,11(2):87-93.
  • 8Srivastava MK,Bosch MJ,Thompson JA,et al.Lung cancer patients'CD4+T cells are activated in vitro by MHC II cell-based vaccines despite the presence of myeloid-derived suppressor cells[J].Cancer Immunol Immunother,2008,57(10):1493-1504.
  • 9Pan Ping-Ying,Ozao Junko,Zhou Zuping,et al.Advancements in Immune Tolerance[J].Adv Drug Deliv Rev,2008,60(2):91-105.
  • 10Pan PY,Wang GX,Yin B,et al.Reversion of immune tolerance in advanced malignancy:modulation of myeloid-derived suppressor cell development by blockade of stem-cell factor function[J].Blood,2008,111(1):219-228.

共引文献3

同被引文献2

引证文献1

二级引证文献3

临床与实验病理学杂志
2013年 第2期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部